Olga Loseva

4.2k total citations
32 papers, 2.0k citations indexed

About

Olga Loseva is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Olga Loseva has authored 32 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in Olga Loseva's work include PARP inhibition in cancer therapy (8 papers), DNA Repair Mechanisms (7 papers) and Invertebrate Immune Response Mechanisms (6 papers). Olga Loseva is often cited by papers focused on PARP inhibition in cancer therapy (8 papers), DNA Repair Mechanisms (7 papers) and Invertebrate Immune Response Mechanisms (6 papers). Olga Loseva collaborates with scholars based in Sweden, United Kingdom and United States. Olga Loseva's co-authors include Thomas Helleday, Ann‐Sofie Jemth, Helen E. Bryant, Ulrich Theopold, Niklas Schultz, Serena Fernandez, Fredrik Johansson, Natalia Issaeva, Eva Petermann and Peter McGlynn and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Molecular Cell.

In The Last Decade

Olga Loseva

32 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Loseva Sweden 22 1.3k 762 520 451 210 32 2.0k
Alexei V. Tulin United States 27 2.2k 1.7× 1.3k 1.7× 354 0.7× 49 0.1× 680 3.2× 69 2.9k
Arno L. Greenleaf United States 41 4.8k 3.7× 656 0.9× 301 0.6× 120 0.3× 420 2.0× 65 5.4k
Hongtao Chen China 18 1.2k 0.9× 127 0.2× 188 0.4× 53 0.1× 170 0.8× 36 1.7k
J.E. Dixon United States 18 2.6k 2.1× 277 0.4× 584 1.1× 46 0.1× 264 1.3× 20 3.3k
Tamar Juven‐Gershon Israel 20 2.1k 1.6× 627 0.8× 119 0.2× 36 0.1× 189 0.9× 35 2.4k
Christian U. Stirnimann Switzerland 15 1.3k 1.0× 472 0.6× 178 0.3× 20 0.0× 137 0.7× 17 2.0k
Ting Han China 22 1.9k 1.5× 310 0.4× 97 0.2× 85 0.2× 479 2.3× 41 2.5k
Joachim Stahl Germany 26 2.3k 1.8× 254 0.3× 202 0.4× 83 0.2× 70 0.3× 62 2.6k
Erhard Wintersberger Austria 30 2.4k 1.9× 1.0k 1.3× 155 0.3× 27 0.1× 254 1.2× 87 3.1k
Jae Hong Seol South Korea 28 2.5k 2.0× 453 0.6× 314 0.6× 22 0.0× 356 1.7× 53 3.0k

Countries citing papers authored by Olga Loseva

Since Specialization
Citations

This map shows the geographic impact of Olga Loseva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Loseva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Loseva more than expected).

Fields of papers citing papers by Olga Loseva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Loseva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Loseva. The network helps show where Olga Loseva may publish in the future.

Co-authorship network of co-authors of Olga Loseva

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Loseva. A scholar is included among the top collaborators of Olga Loseva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Loseva. Olga Loseva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Llona‐Minguez, Sabin, Maria Häggblad, Ulf Märtens, et al.. (2017). Diverse heterocyclic scaffolds as dCTP pyrophosphatase 1 inhibitors. Part 2: Pyridone- and pyrimidinone-derived systems. Bioorganic & Medicinal Chemistry Letters. 27(15). 3219–3225. 5 indexed citations
2.
Llona‐Minguez, Sabin, Andreas Höglund, Elisée Wiita, et al.. (2017). Identification of Triazolothiadiazoles as Potent Inhibitors of the dCTP Pyrophosphatase 1. Journal of Medicinal Chemistry. 60(5). 2148–2154. 18 indexed citations
3.
Llona‐Minguez, Sabin, Maria Häggblad, Ulf Märtens, et al.. (2017). Diverse heterocyclic scaffolds as dCTP pyrophosphatase 1 inhibitors. Part 1: Triazoles, triazolopyrimidines, triazinoindoles, quinoline hydrazones and arylpiperazines. Bioorganic & Medicinal Chemistry Letters. 27(16). 3897–3904. 6 indexed citations
4.
Gustafsson, Robert, Ann‐Sofie Jemth, Nina Gustafsson, et al.. (2016). Crystal Structure of the Emerging Cancer Target MTHFD2 in Complex with a Substrate-Based Inhibitor. Cancer Research. 77(4). 937–948. 71 indexed citations
5.
Zhao, Honglei, Emmanouil G. Sifakis, Noriyuki Sumida, et al.. (2015). PARP1- and CTCF-Mediated Interactions between Active and Repressed Chromatin at the Lamina Promote Oscillating Transcription. Molecular Cell. 59(6). 984–997. 105 indexed citations
6.
Coşkun, Erdem, Paweł Jaruga, Ann‐Sofie Jemth, et al.. (2015). Addiction to MTH1 protein results in intense expression in human breast cancer tissue as measured by liquid chromatography-isotope-dilution tandem mass spectrometry. DNA repair. 33. 101–110. 28 indexed citations
7.
8.
Schultz, Niklas, et al.. (2013). Castration Therapy Results in Decreased Ku70 Levels in Prostate Cancer. Clinical Cancer Research. 19(6). 1547–1556. 51 indexed citations
9.
Svensson, L., Ann‐Sofie Jemth, Matthieu Desroses, et al.. (2011). Crystal structure of human MTH1 and the 8-oxo-dGMP product complex. FEBS Letters. 585(16). 2617–2621. 67 indexed citations
10.
Wang, Zhi, Pavel Hyršl, Torsten G. Loof, et al.. (2010). Pathogen Entrapment by Transglutaminase—A Conserved Early Innate Immune Mechanism. PLoS Pathogens. 6(2). e1000763–e1000763. 147 indexed citations
11.
Loseva, Olga, Ann‐Sofie Jemth, Helen E. Bryant, et al.. (2010). PARP-3 Is a Mono-ADP-ribosylase That Activates PARP-1 in the Absence of DNA. Journal of Biological Chemistry. 285(11). 8054–8060. 131 indexed citations
12.
Agianian, Bogos, Christine Lesch, Olga Loseva, & Mitchell S. Dushay. (2007). Preliminary characterization of hemolymph coagulation in Anopheles gambiae larvae. Developmental & Comparative Immunology. 31(9). 879–888. 24 indexed citations
13.
Hauling, Thomas, Christine Lesch, Marco Fabbri, et al.. (2006). Evidence for an immune function of lepidopteran silk proteins. Biochemical and Biophysical Research Communications. 352(2). 317–322. 19 indexed citations
14.
Scherfer, Christoph, Christine Karlsson, Olga Loseva, et al.. (2004). Isolation and Characterization of Hemolymph Clotting Factors in Drosophila melanogaster by a Pullout Method. Current Biology. 14(7). 625–629. 125 indexed citations
15.
Karlsson, Christine, et al.. (2004). Proteomic Analysis of the Drosophila Larval Hemolymph Clot. Journal of Biological Chemistry. 279(50). 52033–52041. 131 indexed citations
16.
Loseva, Olga & Ylva Engström. (2004). Analysis of Signal-dependent Changes in the Proteome of Drosophila Blood Cells During an Immune Response. Molecular & Cellular Proteomics. 3(8). 796–808. 24 indexed citations
17.
Loseva, Olga, Mohamed A. Ibrahim, Mehmet Candas, et al.. (2002). Changes in protease activity and Cry3Aa toxin binding in the Colorado potato beetle: implications for insect resistance to Bacillus thuringiensis toxins. Insect Biochemistry and Molecular Biology. 32(5). 567–577. 69 indexed citations
18.
Loseva, Olga, et al.. (1998). Application of free‐flow electrophoresis for isolation and purification of proteins and peptides. Electrophoresis. 19(7). 1127–1134. 21 indexed citations
19.
Loseva, Olga, Marina Kirkitadze, Anatoly P. Dobritsa, & Sergey A. Potekhin. (1996). [Thermodynamic analysis of domain organization of Bacillus thuringiensis toxins].. PubMed. 22(12). 900–6. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexei V. Tulin Breakdown of academic impact, for papers by Arno L. Greenleaf Breakdown of academic impact, for papers by Hongtao Chen Breakdown of academic impact, for papers by J.E. Dixon Breakdown of academic impact, for papers by Tamar Juven‐Gershon Breakdown of academic impact, for papers by Christian U. Stirnimann Breakdown of academic impact, for papers by Ting Han Breakdown of academic impact, for papers by Joachim Stahl Breakdown of academic impact, for papers by Erhard Wintersberger Breakdown of academic impact, for papers by Jae Hong Seol
Rankless by CCL
2026